All Stories

  1. Tumor Microenvironment and Wound Healing

    Article • Frontiers in Oncology, October 2019, Frontiers

    Dr Irina Zh Shubina

  2. INFLUENCE OF ANTIBODIES AGAINST CTLA-4 AND PD-1 UPON QUANTITIES OF THEIR TARGET RECEPTORS

    Article • Medical Immunology (Russia), January 2019, SPb RAACI

    Dr Irina Zh Shubina

  3. MicroRNA expression in melanocytes and melanoma cells

    Article • Russian Journal of Biotherapy, November 2018, Publishing House ABV Press

    Dr Irina Zh Shubina

  4. Expression of epithelial marker CK19 in mice with mammary adenocarcinoma afterexposure to fito-anti-estrogen secoisolariciresinol

    Article • Russian Journal of Biotherapy, November 2018, Publishing House ABV Press

    Dr Irina Zh Shubina

  5. Immunological status of cancer patients

    Article • Oncotarget, April 2018, Impact Journals, LLC

    Dr Irina Zh Shubina

  6. Pharmacokinetics of carotenoids and carotene containing compounds

    Article • Russian Journal of Biotherapy, September 2017, Publishing House ABV Press

    Dr Irina Zh Shubina

  7. MODELING OF ORTHOTOPICAL GROWTH OF HUMAN KIDNEY CANCER WITH SUBCUTANEOUS XENOGRAFTS RPOCH1 ON IMMUNODEFICIENT MICE

    Article • Russian Journal of Biotherapy, March 2017, Publishing House ABV Press

    Dr Irina Zh Shubina

  8. Identification of micrometastases

    Article • Oncohematology, March 2016, Publishing House ABV Press

    Dr Irina Zh Shubina

  9. Antitumor immunity

    Article • Russian Journal of Biotherapy, September 2015, Publishing House ABV Press

    Dr Irina Zh Shubina

  10. Immunological Efficiency of MNRI Program at Treatment of Respiratory Diseases

    Article • Frontiers in Immunology, January 2015, Frontiers

    Dr Irina Zh Shubina

  11. Neoadjuvant chemotherapy for advanced ovarian cancer: literature data and in vitro studies

    Article • Tumors of female reproductive system, January 2015, Publishing House ABV Press

    Dr Irina Zh Shubina

  12. Recent achievements of antitumor immunotherapy

    Article • November 2014, Springer Science + Business Media

    Dr Irina Zh Shubina

  13. Experimental Evaluation of Combined Immunotherapy for Tumors

    Article • Bulletin of Experimental Biology and Medicine, September 2014, Springer Science + Business Media

    Dr Irina Zh Shubina

  14. Update on the challenges and recent advances in cancer immunotherapy

    Article • ImmunoTargets and Therapy, June 2013, Taylor & Francis

    Dr Gianfranco Baronzio, Dr Irina Zh Shubina

  15. Immunological Pathogenesis of Septic Reactions and Elimination of Triggers and Mediators of Inflammation

    Article • March 2012, IntechOpen

    Dr Irina Zh Shubina, Dr. Natalia Yu Anisimova

  16. Adoptive Immunotherapy of Malignant Effusions

    Article • January 2012, Springer Science + Business Media

    Dr Irina Zh Shubina

  17. Pathogenesis of Malignant Effusions

    Article • January 2012, Springer Science + Business Media

    Dr Irina Zh Shubina, Dr. Natalia Yu Anisimova

  18. Morphological and Functional Characteristics of Serous Cavities

    Article • January 2012, Springer Science + Business Media

    Dr Irina Zh Shubina, Dr. Natalia Yu Anisimova

  19. Is it necessary to deplete the lymphokine activated killers’ populations of CD4+CD25+ lymphocytes? Regulatory Foxp3-positive T cells within lymphokine activated killers

    Article • Biomedicine & Pharmacotherapy, July 2010, Elsevier

    Dr Irina Zh Shubina

  20. Use of Recombinant Interleukin-2 for Intrapleural Therapy of Tumor-Associated Pleurisy

    Article • Bulletin of Experimental Biology and Medicine, November 2009, Springer Science + Business Media

    Dr Irina Zh Shubina

  21. Combined effect of cisplatin and lymphokine-activated killer cells on A549 cells of non-small cell lung cancer

    Article • Bulletin of Experimental Biology and Medicine, August 2007, Springer Science + Business Media

    Dr Irina Zh Shubina

  22. Selective antitumor activity of lymphokine-activated killer cells in vitro

    Article • Bulletin of Experimental Biology and Medicine, January 2007, Springer Science + Business Media

    Dr Irina Zh Shubina

  23. Effect of “profetal” on differentiation and functional activity of human mononuclear leukocytes

    Article • Bulletin of Experimental Biology and Medicine, April 2006, Springer Science + Business Media

    Dr Irina Zh Shubina

  24. Cytotoxic activity of lymphocytes isolated from mouse liver involved into tumor process

    Article • Bulletin of Experimental Biology and Medicine, January 2006, Springer Science + Business Media

    Dr Irina Zh Shubina

  25. Intravitam quantitative assessment of the intracellular distribution of doxorubicin in tumor cells

    Article • Bulletin of Experimental Biology and Medicine, November 1995, Springer Science + Business Media

    Dr Irina Zh Shubina

  26. Direct evaluation of intracellular accumulation of free and polymer-bound anthracyclines

    Article • Cancer Chemotherapy and Pharmacology, January 1995, Springer Science + Business Media

    Dr Irina Zh Shubina, Dr Jacques Robert

  27. Intracellural accretion of free and nanosphere-encapsulated doxorubicin

    Article • Bulletin of Experimental Biology and Medicine, October 1994, Springer Science + Business Media

    Dr Irina Zh Shubina, Dr Jacques Robert

  28. CD4+/CD25+ T-regulatory cells

    Article • Springer Science + Business Media

    Dr Irina Zh Shubina

  29. LAK immunotherapy in clinical studies

    Article • Springer Science + Business Media

    Dr Irina Zh Shubina

  30. Natural killer T (NKT) cells: Immunophenotype, functional characteristics and significance in clinical practice

    Article • Springer Science + Business Media

    Dr Irina Zh Shubina

  31. Natural killer cells. Lymphokine-activated killers

    Article • Springer Science + Business Media

    Dr Irina Zh Shubina